Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis
- 111 Downloads
Objective and design
The present work investigates the modulation of experimental autoimmune encephalomyelitis (EAE) using genistein before the EAE induction.
Female C57BL/6 mice (n = 96 mice/experiment), 4–6 weeks old, were used to induce the EAE. The mice were divided into three experimental groups: non-immunized group, immunized group (EAE), and immunized and treated with genistein group (Genistein).
Genistein was used at a dose of 200 mg/kg s.c. and were initiated 2 days before the immunization and continued daily until day 6 postimmunization.
Animals were monitored daily for clinical signs of EAE up to day 21. Inflammatory infiltration, demyelination, Toll-like receptor (TLR) expression, cytokines and transcription factors were analyzed in spinal cords.
The present study demonstrates, for the first time, the genistein ability to modulate the factors involved in the innate immune response in the early stages of EAE. The genistein therapy delayed the onset of the disease, with reduced inflammatory infiltration and demyelination. In addition, the expression of TLR3, TLR9 and IFN-β were increased in genistein group, with reduction in the factors of TH1 and Th17 cells.
These findings shed light on the potential of genistein as a prophylactic strategy for multiple sclerosis (MS) prevention.
KeywordsMultiple sclerosis Experimental autoimmune encephalomyelitis IFN-β Toll-like Immune response
This work was supported in part by Grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico [Grant Numbers 481459/2009-0, 303369/2009-4, 306575/2012-4, 470768/2013-4, and 306768/2015-1]; Fundação de Amparo à Pesquisa do Estado de Minas Gerais [grant numbers 02236/10, PPM 0216/10 and PPM 00269-14]; and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior [Grant Number PNPD-2882/2011].
Compliance with ethical standards
Conflict of interest
The authors declare no conflicts of interest.
- 6.Evangelista MG, Castro SBR, Alves CC, Dias AT, Souza VW, Reis LB, Silva LC, Castañon MC, Farias RE, Juliano MA, Ferreira AP. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity. 2016;49:258–67.CrossRefPubMedGoogle Scholar
- 11.Lélu K, Laffont S, Delpy L, Paulet PE, Périnat T, Tschanz SA, Pelletier L, Engelhardt B, Guéry JC. Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol. 2011;187:2386–93.CrossRefPubMedGoogle Scholar
- 14.Castro SBR, Junior COR, Alves CCS, Dias AT, Alves LL, Mazzoccoli L, Mesquita FP, Figueiredo NS, Juliano MA, Castañon MC, Gameiro J, Almeida MV, Teixeira HC, Ferreira AP. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Int Immunopharmacol. 2012;12:465–70.CrossRefPubMedGoogle Scholar
- 16.Dijsselbloem N, Goriely S, Albarani V, Gerlo S, Francoz S, Marine JC, Goldman M, Haegeman G, Vanden Berghe W. A critical role for p53 in the control of NF-kappa B-dependent gene expression in TLR-4-stimulated dendritic cells exposed to genistein. J Immunol. 2007;178:5048–57.CrossRefPubMedGoogle Scholar
- 17.Byun EB, Sung NY, Yang MS, Lee BS, Song DS, Park JN, Kim JH, Jang BS, Choi DS, Park SH, Yu YB, Byun EH. Anti-inflammatory effect of gamma-irradiated genistein through inhibition of NF-κB and MAPK signaling pathway in lipopolysaccharide-induced macrophages. Food Chem Toxicol. 2014;74:255–64.CrossRefPubMedGoogle Scholar
- 19.Buathong N, Poonyachoti S, Deachapunya C. Isoflavone genistein modulates the protein expression of toll-like receptors in cancerous human endometrial cells. J Med Assoc Thai. 2015;98:S31–8.Google Scholar
- 23.Abdul-Majid KB, Wefer J, Stadelmann C, Stefferl A, Lassmann H, Olsson T, Harris RA. Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4-/- and CD8-/- DBA/1 mice defines qualitative roles of different T cell subsets. J Neuroimmunol. 2003;141:10–9.CrossRefPubMedGoogle Scholar
- 29.Dias AT, Castro SBR, Alves CS, Mesquita FP, Figueiredo NS, Evangelista MG, Castanon MCMN., Juliano MA, Ferreira AP. Different MOG35-55 concentrations induce distinguishable inflammation through early regulatory response by IL-10 and TGF-β in mice CNS despite unchanged clinical course. Cell Immunol. 2015;293:87–94.CrossRefPubMedGoogle Scholar
- 37.Khorooshi R, Mørch MT, Holm TH, Berg CT, Dieu RT, Dræby D, Issazadeh-Navikas S, Weiss S, Lienenklaus Owens T. Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol. 2015;130:107–18.CrossRefPubMedPubMedCentralGoogle Scholar